- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Gland Pharma covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
- Blend of compliance (80), financial health (80), director (45) and company-foundation signals.
- Operating for 48+ years.
- Company status is Active as per MCA.
- Annual filings up to date (balance sheet as of Mar 2025).
- Profitable in FY 2025.
- Positive net worth.
- 13 directors on the board.
- Director JIA AI ZHANG has DIN status "Deactivated due to non-filing of DIR-3 KYC".
About Gland Pharma
Gland Pharma is an MCA-registered Indian company: a Public Limited Indian Non-Government Company (CIN L24239TG1978PLC002276). Business overview includes Healthcare (Medical & Laboratory Equipment), incorporated on March 20, 1978 (48+ years old), headquartered in Medchal Malkajgiri District Hyderabad, Telangana, India. The company is currently Active with Active Compliant compliance status.
- Location Sy.No.143-148,150 &151,Near Gandi Maisamma X Roads D.P.Pally,Dundigal, Dundigal - Gandimais, Medchal Malkajgiri District Hyderabad, Telangana - 500043
- Website glandpharma.com
Financial Performance of Gland Pharma
| Metrics | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Profit/Loss | — | — | — | — | — |
| Cash & Bank Balance | — | — | — | — | — |
| Net Worth | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
Financial Ratios
Sign in to view ratio trends
| Ratio | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Net Profit Margin | — | — | — | — | — |
| Debt to EBITDA | — | — | — | — | — |
| Interest Coverage Ratio | — | — | — | — | — |
| Debt to Equity | — | — | — | — | — |
| Return on Equity | — | — | — | — | — |
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| EBITDA Margin | — | — | — | — | — |
| Return on Capital Employed | — | — | — | — | — |
| Earning Per Share | — | — | — | — | — |
EPFO Establishments (1)
Current Directors of Gland Pharma (13)
Charges of Gland Pharma
| Lender | Amount | Status |
|---|---|---|
|
Icici Bank Limited
Creation Date: 10 Sep 2012
|
100.00 cr | Closed |
|
Syndicate Bank
Creation Date: 30 Jun 2012
|
100.00 cr | Closed |
|
The Bank Of Nova Scotia
Creation Date: 06 Sep 2005
|
140.00 cr | Closed |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Manufacturing | - | 100.00 |
Flagged By Authority
Regulatory and exchange flags (preview)
Legal Cases of Gland Pharma
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.